- Trials with a EudraCT protocol (239)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (6)
239 result(s) found for: Epileptic Seizure.
Displaying page 1 of 12.
EudraCT Number: 2004-004146-40 | Sponsor Protocol Number: LEV | Start Date*: 2005-03-10 | |||||||||||
Sponsor Name:ISTITUTI FISIOTERAPICI OSPITALIERI | |||||||||||||
Full Title: pILOT STUDY TO EVALUATE QUALITY OF LIFE, SEIZURES CONTROL AND SIDE EFFECTS IN PATIENTS WITH BRAIN TUMORS AND EPILEPSY TREATED WITH LEVETIRACETAM IN MONOTHERAPY | |||||||||||||
Medical condition: TREATMENT OF EPILEPSY IN PATIENTS WITH BRAIN TUMORS | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-003522-26 | Sponsor Protocol Number: LEVFU05-1 | Start Date*: 2005-07-25 | |||||||||||
Sponsor Name:ISTITUTO C. MONDINO | |||||||||||||
Full Title: Open label, multicenter study of levetiracetam in the treatment of childhood and juvenile absence epilepsy | |||||||||||||
Medical condition: Efficacy and tolerability within one year of levetiracetam | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-003520-18 | Sponsor Protocol Number: LEV05-1 | Start Date*: 2005-07-25 | |||||||||||
Sponsor Name:ISTITUTO C. MONDINO | |||||||||||||
Full Title: Multicenter, double-blind placebo controlled study of levetiracetam in the treatment of childhood and juvenile absence epilepsy. | |||||||||||||
Medical condition: therapy of absence epilepsy | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-004333-57 | Sponsor Protocol Number: N01221 | Start Date*: 2015-02-10 | |||||||||||
Sponsor Name:UCB Japan Co., Ltd. | |||||||||||||
Full Title: A Double-blind, Randomized, Placebo-controlled 5 Parallel Groups, Confirmatory Trial on the Efficacy and Safety of Levetiracetam used as add-on Therapy at doses of 0.5 to 3 g/day in Patients From 1... | |||||||||||||
Medical condition: Epilepsies Partial | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-003961-49 | Sponsor Protocol Number: P261-301 | Start Date*: 2015-03-03 | |||||||||||
Sponsor Name:Upsher-Smith Laboratories, Inc. | |||||||||||||
Full Title: A Randomized, Double-Blind, Placebo Controlled Trial Examining the Safety and Efficacy of Midazolam Intranasal Spray (USL261) for the Treatment of Intermittent Bouts of Increased Seizure Activity i... | |||||||||||||
Medical condition: Epilepsy | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) CZ (Completed) IT (Completed) DE (Completed) ES (Completed) AT (Completed) LT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-002713-32 | Sponsor Protocol Number: N01367 | Start Date*: 2015-03-11 | |||||||||||
Sponsor Name:Korea UCB Co. Ltd. | |||||||||||||
Full Title: A Multi-Center, Open-label, Randomized Study to Evaluate the Long Term Effectiveness of Levetiracetam as Monotherapy in Comparison With Oxcarbazepine in Subjects With Newly or Recently Diagnosed Pa... | |||||||||||||
Medical condition: Epilepsy | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-004878-15 | Sponsor Protocol Number: LAM115376 | Start Date*: 2016-12-21 | |||||||||||
Sponsor Name:GlaxoSmithKline K.K. (GSK) | |||||||||||||
Full Title: A multi-center, uncontrolled, open-label, evaluation of lamotrigine monotherapy in adult subjects with newly diagnosed epilepsy or recurrent epilepsy (currently untreated). | |||||||||||||
Medical condition: Epilepsy | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-004377-16 | Sponsor Protocol Number: N01375 | Start Date*: 2015-07-24 | |||||||||||
Sponsor Name:UCB Japan Co. Ltd. | |||||||||||||
Full Title: An Open-label, Randomized, Multicenter Study to Evaluate the Efficacy and Safety of Levetiracetam Used as Monotherapy in Newly or Recently Diagnosed Epilepsy Patients Aged Older Than or Equal to 16... | |||||||||||||
Medical condition: Focal Epilepsy | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-004334-26 | Sponsor Protocol Number: N01222 | Start Date*: 2015-02-10 | |||||||||||
Sponsor Name:UCB Japan Co. Ltd | |||||||||||||
Full Title: A Multicenter, Open, Long-term Follow-up Study to Evaluate the Safety and Efficacy of L059 (Levetiracetam) at Individual Optimal Dose Ranging From 500 to 3000 mg/Day in Twice Daily Administration i... | |||||||||||||
Medical condition: Epilepsies Partial | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-004827-30 | Sponsor Protocol Number: RASLOW | Start Date*: 2017-03-21 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA "BIANCHI-MELACRINO-MORELLI" | |||||||||||||
Full Title: RAPID VERSUS SLOW WITHDRAWAL OF ANTIEPILEPTIC MONOTHERAPY IN TWO-YEAR SEIZURE-FREE ADULTS PATIENTS WITH EPILEPSY (RASLOW) STUDY: A PRAGMATIC MULTICENTRE, PROSPECTIVE, RANDOMIZED, CONTROLLED STUDY. | |||||||||||||
Medical condition: Epilepsy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-005722-23 | Sponsor Protocol Number: N01274 | Start Date*: 2007-05-15 | |||||||||||
Sponsor Name:UCB Pharma S.A. | |||||||||||||
Full Title: Open-label, single-arm, multi-center, pharmacokinetic, safety and tolerability study of levetiracetam intravenous infusion in children (4 - 16 years old) with epilepsy. | |||||||||||||
Medical condition: Epilepsy | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) DE (Completed) FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-004511-27 | Sponsor Protocol Number: S64647 | Start Date*: 2021-08-05 | |||||||||||
Sponsor Name:University Hospital Leuven | |||||||||||||
Full Title: Add-on clioquinol in drug-resistant childhood epilepsy: an exploratory study | |||||||||||||
Medical condition: Drug resistant epilepsy in children | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-004382-25 | Sponsor Protocol Number: N01363 | Start Date*: 2015-02-24 | |||||||||||
Sponsor Name:UCB Japan Co. Ltd. | |||||||||||||
Full Title: An Open-label, Single-arm, Multicenter Study to Evaluate the Efficacy and Safety of Adjunctive Treatment With Levetiracetam in Japanese Patients (≥4 to <16 Years) With Uncontrolled Generalized Toni... | |||||||||||||
Medical condition: - Epilepsy - Generalized Tonic-clonic Seizures | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-004465-87 | Sponsor Protocol Number: CTRI476BRU02 | Start Date*: 2016-05-04 | ||||||||||||||||
Sponsor Name:Novartis Pharmaceuticals | ||||||||||||||||||
Full Title: A 24-week Prospective Open-label Multicenter Study to Evaluate the Effect on Seizure Frequency, Safety and Tolerability of Oxcarbazepine Monotherapy in Children With Partial Seizures | ||||||||||||||||||
Medical condition: Epilepsy, Partial Seizures | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: Outside EU/EEA | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2015-001549-96 | Sponsor Protocol Number: SP1042 | Start Date*: 2016-03-17 | |||||||||||
Sponsor Name:UCB BioPharma SPRL | |||||||||||||
Full Title: A MULTICENTER, OPEN-LABEL, FOLLOW-UP STUDY TO ASSESS THE LONG-TERM USE OF LACOSAMIDE (FLEXIBLE DOSE FROM 200 TO 600 MG/DAY) USED AS MONOTHERAPY IN SUBJECTS WHO COMPLETED SP0994 AND RECEIVED LACOSA... | |||||||||||||
Medical condition: Epilepsy with partial-onset seizures or generalized tonic-clonic seizures | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Completed) SE (Completed) DE (Completed) LV (Completed) BG (Completed) PL (Completed) FR (Completed) RO (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-001478-30 | Sponsor Protocol Number: EP0151 | Start Date*: 2020-10-29 | |||||||||||
Sponsor Name:UCB Biopharma SRL | |||||||||||||
Full Title: A Multicenter, Open-Label, Follow-Up Study to Assess the Long-Term Use of Oral Lacosamide in Study Participants Who Completed EP0034 or SP848 and Received Lacosamide Treatment | |||||||||||||
Medical condition: Epilepsy | |||||||||||||
|
|||||||||||||
Population Age: Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Trial now transitioned) RO (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-004401-32 | Sponsor Protocol Number: N01159 | Start Date*: 2015-03-02 | |||||||||||
Sponsor Name:UCB Japan Co. Ltd. | |||||||||||||
Full Title: A Double-blind, Multicenter, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of Adjunctive Treatment With Oral Levetiracetam, in Epilepsy Patients Aged ≥16 Years, With Gene... | |||||||||||||
Medical condition: - Epilepsy - Generalized Tonic-Clonic Seizures | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-004586-84 | Sponsor Protocol Number: N01364 | Start Date*: 2015-11-12 | ||||||||||||||||
Sponsor Name:UCB Pharma SA | ||||||||||||||||||
Full Title: A multicenter, open-label, randomized, parallel-group, active-controlled study comparing the efficacy and safety of Levetiracetam to Carbamazepine used as monotherapy in subjects (≥16 years) newly ... | ||||||||||||||||||
Medical condition: Epilepsy Partial Seizures | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: Outside EU/EEA | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2010-020871-22 | Sponsor Protocol Number: AGG-901 | Start Date*: 2011-02-02 | |||||||||||
Sponsor Name:West-ward Pharmaceutical Corporation | |||||||||||||
Full Title: An international, double-blind, parallel-group, placebo-controlled, randomized study: evaluation of the efficacy and safety of phenobarbital as adjunctive therapy in participants (≥ 17 to 70 years ... | |||||||||||||
Medical condition: Epilepsy with partial onset seizures (complex or simple with motor symptoms only) whether or not secondarily generalized. | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BG (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-018284-42 | Sponsor Protocol Number: LEVVPA | Start Date*: 2012-12-19 | |||||||||||
Sponsor Name:University Medical Centre Groningen | |||||||||||||
Full Title: Double-blind randomized trial comparing efficacy, safety and tolerance between Levetiracetam monotherapy and Valproic acid monotherapy in children with newly diagnosed epilepsy | |||||||||||||
Medical condition: epilepsy | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.